We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.53B
AUM Growth
+$68.3M
Cap. Flow
+$49.5M
Cap. Flow %
1.96%
Top 10 Hldgs %
16.36%
Holding
1,009
New
121
Increased
515
Reduced
261
Closed
111

Top Sells

Rank Stock Value
1
OII icon
Oceaneering
OII
+$17.5M
2
ZBRA icon
Zebra Technologies
ZBRA
+$12.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.2M
4
IPGP icon
IPG Photonics
IPGP
+$7.17M
5
IRBT
iRobot
IRBT
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 26.96%
2 Industrials 13.04%
3 Healthcare 11.78%
4 Consumer Discretionary 8.78%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVHC
1001
DELISTED
Envision Healthcare Holdings Inc
EVHC
-5,337
Closed -$203K
ARMO
1002
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
-74,279
Closed -$2.17M
TWX
1003
DELISTED
Time Warner Inc
TWX
-9,552
Closed -$931K
MON
1004
DELISTED
Monsanto Co
MON
-8,426
Closed -$1.06M
GXP
1005
DELISTED
Great Plains Energy Incorporated
GXP
-27,001
Closed -$842K
AVXS
1006
DELISTED
AveXis, Inc. Common Stock
AVXS
-4,402
Closed -$931K
BEAT
1007
DELISTED
BioTelemetry, Inc.
BEAT
-18,094
Closed -$623K
WR
1008
DELISTED
Westar Energy Inc
WR
-20,276
Closed -$1.05M
EE
1009
DELISTED
El Paso Electric Company
EE
-4,237
Closed -$210K

Similar funds

Vident Investment Advisory's Q2 2018 Portfolio in Review

As of Q2 2018, Vident Investment Advisory held 1,009 positions worth $2.53B, up 2.8% from $2.46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Investment Advisory's Q2 2018 filing shows 121 new, 515 increased, 261 reduced and 111 closed positions. Its largest new stake was Arcus Biosciences: 156,139 shares worth $1.91M. The largest sale was Oceaneering, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Vident Investment Advisory's largest Q2 2018 buy was Arcus Biosciences: 156,139 shares worth $1.91M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $29.4M increase.
  • Vident Investment Advisory's biggest Q2 2018 reduction was Oceaneering, cutting an estimated $17.5M.
  • Vident Investment Advisory fully exited FIRST TRUST HIGH INCOME LONG/SHORT FUND in Q2 2018, selling an estimated $5.5M.
  • Vident Investment Advisory's ten largest holdings make up 16% of its $2.53B portfolio in Q2 2018.
  • Vident Investment Advisory opened 121 new positions and closed 111 in Q2 2018.
  • Vident Investment Advisory's portfolio value rose 2.8% quarter-over-quarter to $2.53B.

Based on Vident Investment Advisory's 13F filing for Q2 2018, filed 14 Aug 2018.